Altis Biosystems

Altis Biosystems, Inc. has developed a patent-pending stem cell technology, recreating both the small

and large human intestinal epithelium for drug screening and microbiome research for pharmaceutical

and biotechnology companies. This is important because, until now, pharmaceutical companies only had

the ability to use cancer cell lines and animal models before human testing. Altis' platform is high

throughput, scalable, and reproducible. Altis provides a variety of services on its platform for customers,

including toxicology, permeability, protein/gene expression, transport, etc. In addition, Altis is able to ship

its platform to customers if they prefer to conduct testing in their own facilities.